| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | 0.018 | 0.9 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |